507 related articles for article (PubMed ID: 25380105)
1. Cost-consequence analysis of antibiotic-impregnated shunts and external ventricular drains in hydrocephalus.
Edwards NC; Engelhart L; Casamento EM; McGirt MJ
J Neurosurg; 2015 Jan; 122(1):139-47. PubMed ID: 25380105
[TBL] [Abstract][Full Text] [Related]
2. Silver-impregnated, antibiotic-impregnated or non-impregnated ventriculoperitoneal shunts to prevent shunt infection: the BASICS three-arm RCT.
Mallucci CL; Jenkinson MD; Conroy EJ; Hartley JC; Brown M; Moitt T; Dalton J; Kearns T; Griffiths MJ; Culeddu G; Solomon T; Hughes D; Gamble C;
Health Technol Assess; 2020 Mar; 24(17):1-114. PubMed ID: 32238262
[TBL] [Abstract][Full Text] [Related]
3. Cost savings associated with antibiotic-impregnated shunt catheters in the treatment of adult and pediatric hydrocephalus.
Parker SL; McGirt MJ; Murphy JA; Megerian JT; Stout M; Engelhart L
World Neurosurg; 2015 Mar; 83(3):382-6. PubMed ID: 24933241
[TBL] [Abstract][Full Text] [Related]
4. A new Hydrocephalus Clinical Research Network protocol to reduce cerebrospinal fluid shunt infection.
Kestle JR; Holubkov R; Douglas Cochrane D; Kulkarni AV; Limbrick DD; Luerssen TG; Jerry Oakes W; Riva-Cambrin J; Rozzelle C; Simon TD; Walker ML; Wellons JC; Browd SR; Drake JM; Shannon CN; Tamber MS; Whitehead WE;
J Neurosurg Pediatr; 2016 Apr; 17(4):391-6. PubMed ID: 26684763
[TBL] [Abstract][Full Text] [Related]
5. Comparative effectiveness of antibiotic-impregnated shunt catheters in the treatment of adult and pediatric hydrocephalus: analysis of 12,589 consecutive cases from 287 US hospital systems.
Parker SL; McGirt MJ; Murphy JA; Megerian JT; Stout M; Engelhart L
J Neurosurg; 2015 Feb; 122(2):443-8. PubMed ID: 25415066
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial-impregnated and -coated shunt catheters for prevention of infections in patients with hydrocephalus: a systematic review and meta-analysis.
Konstantelias AA; Vardakas KZ; Polyzos KA; Tansarli GS; Falagas ME
J Neurosurg; 2015 May; 122(5):1096-112. PubMed ID: 25768831
[TBL] [Abstract][Full Text] [Related]
7. Has the introduction of antibiotic-impregnated external ventricular drain catheters changed the nature of the microorganisms cultured in patients with drain-related infection? A single neurosurgical centre's experience.
Talibi S; Tarnaris A; Shaw SA
Br J Neurosurg; 2016 Oct; 30(5):560-6. PubMed ID: 27195449
[TBL] [Abstract][Full Text] [Related]
8. Effects of antibiotic-impregnated external ventricular drains on bacterial culture results: an in vitro analysis.
Stevens EA; Palavecino E; Sherertz RJ; Shihabi Z; Couture DE
J Neurosurg; 2010 Jul; 113(1):86-92. PubMed ID: 19961313
[TBL] [Abstract][Full Text] [Related]
9. Antibiotic-impregnated shunt systems versus standard shunt systems: a meta- and cost-savings analysis.
Klimo P; Thompson CJ; Ragel BT; Boop FA
J Neurosurg Pediatr; 2011 Dec; 8(6):600-12. PubMed ID: 22132919
[TBL] [Abstract][Full Text] [Related]
10. Antibiotic Impregnated External Ventricular Drains: Meta and Cost Analysis.
Root BK; Barrena BG; Mackenzie TA; Bauer DF
World Neurosurg; 2016 Feb; 86():306-15. PubMed ID: 26409081
[TBL] [Abstract][Full Text] [Related]
11. Antibiotic-impregnated catheters for the prevention of CSF shunt infections: a systematic review and meta-analysis.
Thomas R; Lee S; Patole S; Rao S
Br J Neurosurg; 2012 Apr; 26(2):175-84. PubMed ID: 21973061
[TBL] [Abstract][Full Text] [Related]
12. Cost analysis of antibiotic-impregnated catheters in the treatment of hydrocephalus in adult patients.
Farber SH; Parker SL; Adogwa O; Rigamonti D; McGirt MJ
World Neurosurg; 2010; 74(4-5):528-31. PubMed ID: 21492607
[TBL] [Abstract][Full Text] [Related]
13. The British antibiotic and silver-impregnated catheters for ventriculoperitoneal shunts multi-centre randomised controlled trial (the BASICS trial): study protocol.
Jenkinson MD; Gamble C; Hartley JC; Hickey H; Hughes D; Blundell M; Griffiths MJ; Solomon T; Mallucci CL
Trials; 2014 Jan; 15():4. PubMed ID: 24383496
[TBL] [Abstract][Full Text] [Related]
14. Antibiotic or silver versus standard ventriculoperitoneal shunts (BASICS): a multicentre, single-blinded, randomised trial and economic evaluation.
Mallucci CL; Jenkinson MD; Conroy EJ; Hartley JC; Brown M; Dalton J; Kearns T; Moitt T; Griffiths MJ; Culeddu G; Solomon T; Hughes D; Gamble C;
Lancet; 2019 Oct; 394(10208):1530-1539. PubMed ID: 31522843
[TBL] [Abstract][Full Text] [Related]
15. Do antibiotic-impregnated shunts in hydrocephalus therapy reduce the risk of infection? An observational study in 258 patients.
Ritz R; Roser F; Morgalla M; Dietz K; Tatagiba M; Will BE
BMC Infect Dis; 2007 May; 7():38. PubMed ID: 17488498
[TBL] [Abstract][Full Text] [Related]
16. Antibiotic-impregnated catheters reduce ventriculoperitoneal shunt infection rate in high-risk newborns and infants.
Raffa G; Marseglia L; Gitto E; Germanò A
Childs Nerv Syst; 2015 Jul; 31(7):1129-38. PubMed ID: 25820704
[TBL] [Abstract][Full Text] [Related]
17. Response.
Edwards NC; McGirt MJ; Engelhart L
J Neurosurg; 2015 Jan; 122(1):137-8. PubMed ID: 25705753
[No Abstract] [Full Text] [Related]
18. Clinical and economic consequences of antibiotic-impregnated cerebrospinal fluid shunt catheters.
Eymann R; Chehab S; Strowitzki M; Steudel WI; Kiefer M
J Neurosurg Pediatr; 2008 Jun; 1(6):444-50. PubMed ID: 18518694
[TBL] [Abstract][Full Text] [Related]
19. Editorial: industry-sponsored research.
Kestle JR
J Neurosurg; 2015 Jan; 122(1):136-8. PubMed ID: 25380108
[No Abstract] [Full Text] [Related]
20. Reduction of ventriculostomy-associated CSF infection with antibiotic-impregnated catheters in pediatric patients: a single-institution study.
Lang SS; Zhang B; Yver H; Palma J; Kirschen MP; Topjian AA; Kennedy B; Storm PB; Heuer GG; Mensinger JL; Huh JW
Neurosurg Focus; 2019 Aug; 47(2):E4. PubMed ID: 31370025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
